In light of the significant in vitro anti‐proliferative effects of PPARG inhibition on AML cells, we sought to determine whether inhibition of the PPARG pathway could also limit the ability of AML cells to generate tumors in vivo (i.e., tumor initiation capacity). The gene discussed is PPARG; the disease is neoplasm.